Mouwasat Medical Services Company (4002)

192.20 +2.80 (+1.48%)
Closed SAR Disclaimer

4002 Financial Summary

For the nine months ended 30 September 2021,Mouwasat Medical Services Company SJSC revenues increased5% to SAR1.59B. Net income increased 12% to SAR431.2M.Revenues reflect Pharmaceuticals segment increase of 15% toSAR202.7M. Net income benefited from Sales & Distributiondecrease of 14% to SAR79.2M (expense), Share of Income froman Associate increase from SAR2.8M to SAR8.2M (income).
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
4002
Gross margin TTM 46.79%
Operating margin TTM 28.88%
Net Profit margin TTM 28.25%
Return on Investment TTM 19.88%
Total Revenue
Net Income
Title
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020
Total Revenue 530.98 526.70 534.12 533.60
Gross Profit 244.40 246.46 254.30 249.21
Operating Income 150.10 154.77 158.49 150.35
Net Income 142.66 141.35 147.19 143.30
Clear All
0Selected
Please try another search
4002
Quick Ratio MRQ 1.49
Current Ratio MRQ 1.78
LT Debt to Equity MRQ 22.7%
Total Debt to Equity MRQ 32.04%
Total Assets
Total Liabilities
Title
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020
Total Assets 3,928.12 3,796.17 3,908.36 3,648.78
Total Liabilities 1,467.79 1,478.50 1,482.03 1,369.64
Total Equity 2,460.33 2,317.68 2,426.33 2,279.14
Clear All
0Selected
Please try another search
4002
Cash Flow/Share TTM 7.55
Revenue/Share TTM 21.25
Operating Cash Flow 64.68%
Cash
Net Change in Cash
Title
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020
Cash From Operating Activities 451.55 357.06 159.20 482.53
Cash From Investing Activities -252.41 -149.28 -47.10 -318.96
Cash From Financing Activities -280.59 -257.85 4.54 -208.04
Net Change in Cash -81.44 -50.07 116.64 -44.47
Clear All
0Selected
Please try another search

* In Millions of SAR (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.